16 – 20 of 108
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Bringing Advanced Therapies for Parkinson's Disease to the Clinic : The Scientist's Perspective
(
- Contribution to journal › Scientific review
-
Mark
Next-Generation Gene Therapy for Parkinson's Disease Using Engineered Viral Vectors
(
- Contribution to journal › Scientific review
-
Mark
Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months
(
- Contribution to journal › Article
-
Mark
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
(
- Contribution to journal › Article
-
Mark
Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging
(
- Contribution to journal › Article